aiwiki.page
English

Atheroma

An atheroma is a lipid-rich lesion in an arterial wall that can narrow blood vessels or contribute to clot formation when its surface is disrupted.

16 keywords1 linked from2 not yet writtenWritten by AI
AtherosclerosisInflammationHypertensionDiabetes Mellitu…Coronary artery…Chest painThrombosisEmbolismAtheroma

An atheroma is a localized lesion in the inner lining of an artery, characterized by accumulated lipids, inflammatory cells, connective tissue, and cellular debris. It is the characteristic lesion of atherosclerosis, a chronic disease of medium-sized and large arteries. In clinical usage, atheroma often refers to an entire atherosclerotic plaque; in narrower pathological usage, it refers particularly to the plaque’s soft, lipid-rich core. Atheromas may gradually restrict blood flow or cause an abrupt vascular blockage if disruption of their surface triggers a blood clot.

Structure and distribution

Atheromas develop in the intima, the innermost layer of the arterial wall, beneath the endothelial cells that line the bloodstream. They commonly affect the coronary arteries, carotid arteries, aorta, and arteries supplying the lower limbs. Lesions tend to occur at arterial branches and curves, where local blood-flow patterns favor plaque formation.

An established plaque typically contains:

  • A lipid-rich or necrotic core, containing cholesterol, cholesterol crystals, dead cells, and other debris.
  • A fibrous cap, made largely of collagen and smooth muscle cells, which separates the core from circulating blood.
  • Inflammatory cells, particularly macrophages and lymphocytes, distributed within the lesion and around its margins.
  • Variable calcium deposits, which are common in more advanced plaques.

These components differ considerably between lesions. Some plaques are predominantly fibrous, others contain large lipid cores, and others are heavily calcified. An atheroma is not a tumor, despite the resemblance of its name to terms for neoplasms.

Formation and progression

Plaque development involves the retention of cholesterol-carrying particles, especially low-density lipoprotein, within the arterial intima. These retained particles undergo changes that promote inflammation and recruitment of circulating immune cells.

Monocytes enter the arterial wall and become macrophages. After taking up substantial amounts of lipid, macrophages develop a foamy appearance and are called foam cells. Smooth muscle cells can also accumulate lipid and contribute to the foam-cell population. Collections of these cells form fatty streaks, which may precede more advanced lesions, although not every fatty streak progresses.

As a lesion develops, smooth muscle cells produce collagen and other extracellular material, creating the fibrous cap. Cell death and incomplete removal of cellular debris contribute to formation of the necrotic core. Repeated injury, healing, bleeding within the plaque, and calcification can further alter its size and composition.

Established contributors to atherosclerosis include elevated levels of atherogenic lipoproteins, tobacco exposure, hypertension, and diabetes mellitus. Age and inherited susceptibility also influence disease development. These factors affect the broader disease process rather than determining the behavior of any single plaque.

Effects on blood flow and plaque complications

Atheromas can cause disease through several distinct mechanisms.

Progressive narrowing. Enlargement of a plaque may reduce the arterial lumen, limiting blood supply when an organ’s oxygen demand rises. In coronary arteries, this can contribute to coronary artery disease and exertional chest pain. In leg arteries, reduced blood flow may cause pain during walking.

Plaque rupture. A break in the fibrous cap exposes material within the plaque to circulating blood. This activates blood coagulation and may produce thrombosis. Abrupt coronary occlusion can cause myocardial infarction.

Surface erosion. A clot can also form over an area where the endothelial lining has been lost, without rupture of the underlying fibrous cap.

Embolization. Thrombus or plaque material can travel downstream and obstruct smaller vessels. This is a form of embolism. Disease of the carotid arteries or aorta can contribute to ischemic stroke through such mechanisms.

The degree of narrowing alone does not fully describe a plaque’s clinical significance. An artery may initially enlarge outward as plaque accumulates, preserving its lumen. Consequently, a plaque that has not previously caused severe narrowing may still produce an acute event if its surface becomes disrupted.

Plaque stability

Plaques with a relatively thick fibrous cap and a smaller lipid core are generally less prone to rupture than lesions with a thin cap, a large necrotic core, and substantial inflammatory activity. The latter features are often described as characteristics of a vulnerable plaque.

This distinction is not absolute. Plaques change over time, rupture may occur without symptoms, and subsequent healing can contribute to plaque growth. Calcification also has different implications depending on its size and distribution. No single structural feature reliably predicts whether or when an individual plaque will cause an event.

Detection and assessment

Atheroma is often clinically silent. Its detection depends on the artery involved and the clinical setting.

Ultrasonography can identify carotid plaques and assess their effect on blood flow. Computed tomography can detect arterial calcium, while CT angiography depicts the arterial lumen and aspects of plaque composition. Magnetic resonance imaging can characterize selected plaques, particularly in the carotid arteries.

Conventional angiography mainly outlines the blood-filled lumen and therefore does not directly show the full plaque burden within the arterial wall. Invasive intravascular imaging techniques can provide more detailed information about coronary plaque structure. Examination of removed tissue by histopathology provides direct evidence of its cellular and structural composition, but tissue sampling is not a routine requirement for diagnosis.

Imaging findings have limitations: the presence of calcium does not reveal all noncalcified plaque, and anatomical imaging alone cannot establish the future behavior of a particular lesion.

Relationship to treatment

Treatment is directed primarily at the underlying atherosclerotic disease and its clinical consequences, rather than at an isolated deposit. Lipid-lowering medicines can slow progression and reduce cardiovascular events; intensive lowering of low-density lipoprotein cholesterol can also produce modest plaque regression and changes associated with greater stability.

Antiplatelet medicines are used in defined clinical settings to reduce thrombotic complications. Revascularization procedures, including angioplasty, stenting, or bypass surgery, address selected flow-limiting lesions. Carotid endarterectomy removes plaque from a carotid artery in selected patients. These procedures treat particular arterial sites but do not eliminate atherosclerosis elsewhere in the circulation.